Feedback / Questions
tibulizumab (ZB-106) - Zura Bio
https://www.businesswire.com/news/home/20251113296574/en/Zura-Bio-Reports-Third-Quarter-2025-Financial-Results-and-Recent-Corporate-Updates
Nov 13, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next